Biotricity, Inc.

OTCPK:BTCY Stock Report

Market Cap: US$6.5m

Biotricity Management

Management criteria checks 2/4

Biotricity's CEO is Waqaas Al-Siddiq, appointed in Jul 2014, has a tenure of 10.42 years. total yearly compensation is $1.25M, comprised of 38.3% salary and 61.7% bonuses, including company stock and options. directly owns 3.19% of the company’s shares, worth $207.33K. The average tenure of the management team and the board of directors is 7.2 years and 7.3 years respectively.

Key information

Waqaas Al-Siddiq

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage38.3%
CEO tenure10.4yrs
CEO ownership3.2%
Management average tenure7.2yrs
Board average tenure7.3yrs

Recent management updates

Recent updates

Investors Give Biotricity, Inc. (NASDAQ:BTCY) Shares A 38% Hiding

Jan 26
Investors Give Biotricity, Inc. (NASDAQ:BTCY) Shares A 38% Hiding

Many Still Looking Away From Biotricity, Inc. (NASDAQ:BTCY)

Oct 26
Many Still Looking Away From Biotricity, Inc. (NASDAQ:BTCY)

Biotricity GAAP EPS of -$0.09, revenue of $2.06M

Aug 15

Biotricity, Inc.: A First Take

Jul 28

Is Biotricity (NASDAQ:BTCY) Using Debt In A Risky Way?

Apr 09
Is Biotricity (NASDAQ:BTCY) Using Debt In A Risky Way?

Does Biotricity (NASDAQ:BTCY) Have A Healthy Balance Sheet?

Dec 11
Does Biotricity (NASDAQ:BTCY) Have A Healthy Balance Sheet?

Biotricity: Capital Raise Leads To Buying Opportunity

Aug 31

CEO Compensation Analysis

How has Waqaas Al-Siddiq's remuneration changed compared to Biotricity's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$16m

Jun 30 2024n/an/a

-US$18m

Mar 31 2024US$1mUS$480k

-US$15m

Dec 31 2023n/an/a

-US$15m

Sep 30 2023n/an/a

-US$17m

Jun 30 2023n/an/a

-US$18m

Mar 31 2023US$1mUS$480k

-US$20m

Dec 31 2022n/an/a

-US$21m

Sep 30 2022n/an/a

-US$23m

Jun 30 2022n/an/a

-US$29m

Mar 31 2022US$887kUS$480k

-US$30m

Dec 31 2021n/an/a

-US$30m

Sep 30 2021n/an/a

-US$27m

Jun 30 2021n/an/a

-US$19m

Mar 31 2021US$891kUS$390k

-US$16m

Dec 31 2020n/an/a

-US$16m

Sep 30 2020n/an/a

-US$14m

Jun 30 2020n/an/a

-US$13m

Mar 31 2020US$2mUS$390k

-US$11m

Dec 31 2019n/an/a

-US$8m

Sep 30 2019n/an/a

-US$8m

Jun 30 2019n/an/a

-US$8m

Mar 31 2019US$2mUS$360k

-US$9m

Dec 31 2018n/an/a

-US$10m

Sep 30 2018n/an/a

-US$9m

Jun 30 2018n/an/a

-US$9m

Mar 31 2018US$1mUS$310k

-US$9m

Compensation vs Market: Waqaas's total compensation ($USD1.25M) is above average for companies of similar size in the US market ($USD646.54K).

Compensation vs Earnings: Waqaas's compensation has increased whilst the company is unprofitable.

CEO

Waqaas Al-Siddiq (39 yo)

10.4yrs

Tenure

US$1,254,153

Compensation

Dr. Waqaas Al-Siddiq, PhD, has founded Biotricity Inc.(formerly known as iMedical Innovations Inc.) in July 2014 and has been its Chairman, President and Chief Executive Officer since July 2014. Dr. Al-Sid...

Leadership Team

NamePositionTenureCompensationOwnership
Waqaas Al-Siddiq
Founder10.4yrsUS$1.25m3.19%
$ 207.3k
S. Ayanoglou
Chief Financial Officer7.2yrsUS$562.00k1.11%
$ 72.4k
Amjad Talpur
Senior Director of Operationsno datano datano data
Matt Zabel
Vice President of Sales & Strategyno datano datano data
Amir Ali
Chief Development Officerno datano datano data
Fareeha Siddiqui
Executive Vice President of Healthcare Solutionsless than a yearno datano data

7.2yrs

Average Tenure

Experienced Management: BTCY's management team is seasoned and experienced (7.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Waqaas Al-Siddiq
Founder10.4yrsUS$1.25m3.19%
$ 207.3k
John Simpson
Chair of Scientific & Medical Alliance Board and Chair of Science Alliance Board4.8yrsno datano data
Daniel Sands
Member of the Board of Advisors8.6yrsno datano data
Ronald McClurg
Independent Director2.6yrsUS$32.62k0.14%
$ 9.4k
David Rosa
Independent Director8.6yrsUS$60.00k1.21%
$ 79.0k
J. Rice
Member of the Board of Advisors8.5yrsno datano data
John Rother
Member of the Board of Advisors8.6yrsno datano data
Thomas Nelson
Member of the Board of Advisors8.5yrsno datano data
Donald Cross
Member of Scientific & Medical Alliance Board6.1yrsno datano data
Edward Lazaga
Member of Scientific & Medical Alliance Board6.1yrsno datano data
Imran Mohiuddin
Member of Scientific & Medical Alliance Board6.1yrsno datano data
Radoslaw Kiesz
Member of Scientific & Medical Alliance Board6.1yrsno datano data

7.3yrs

Average Tenure

64yo

Average Age

Experienced Board: BTCY's board of directors are considered experienced (7.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 06:44
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biotricity, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kevin DedeH.C. Wainwright & Co.
Jason WittesNorthland Capital Markets